Stock listing

IRD Stock Price, News, Filings & Events — Opus Genetics, Inc.

Selected listing: IRD · BOATS · USD · US

This page tracks Opus Genetics, Inc.'s IRD:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IRD:BOATS. IRD:BOATS is the stock-level entry point for investors researching Opus Genetics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Opus Genetics, Inc. is a public company traded under the ticker IRD in the American market. The company has a market capitalization of approximately $254.3 million. Opus Genetics focuses on developing innovative solutions in the field of genetic medicine.

IRD:BOATSUSDUSUpdated September 11, 2026
Opus Genetics, Inc. logo
Ticker
IRD:BOATS
Asset type
Stock
Market cap
$502.5M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
BOATS
Currency
USD

Opus Genetics, Inc. IRD:BOATS stock context

This page tracks Opus Genetics, Inc.'s IRD:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IRD:BOATS. IRD:BOATS is the stock-level entry point for investors researching Opus Genetics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Opus Genetics, Inc. is a public company traded under the ticker IRD in the American market. The company has a market capitalization of approximately $254.3 million. Opus Genetics focuses on developing innovative solutions in the field of genetic medicine.

Latest news from Opus Genetics, Inc.

All Opus Genetics, Inc. news →

Research Opus Genetics, Inc.

Alternate listings